10-113884281-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_198514.4(NHLRC2):c.940G>A(p.Val314Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 1,608,448 control chromosomes in the GnomAD database, including 63,487 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Consequence
NM_198514.4 missense
Scores
Clinical Significance
Conservation
Publications
- fibrosis, neurodegeneration, and cerebral angiomatosisInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.250 AC: 37925AN: 151572Hom.: 5157 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.276 AC: 69339AN: 250812 AF XY: 0.273 show subpopulations
GnomAD4 exome AF: 0.279 AC: 406600AN: 1456756Hom.: 58325 Cov.: 30 AF XY: 0.277 AC XY: 201023AN XY: 724860 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.250 AC: 37937AN: 151692Hom.: 5162 Cov.: 32 AF XY: 0.253 AC XY: 18745AN XY: 74144 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
NHLRC2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at